Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

4
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
4
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

2
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
2
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

737
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
737
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

2
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
2
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice to "Applying spectral analysis to the arterial pulse to discriminate cardiovascular side effects following administration of Moderna's mRNA-1273 vaccine" [Eur. J. Pharmacol. 1007 (2025) 178269].

European journal of pharmacology·2026
Same author

Cardiorenal protective effects of anti-diabetic drugs in early stage Cardiovascular-Kidney-Metabolic Syndrome: A multicenter, time-varying analysis.

Diabetes research and clinical practice·2026
Same author

Tai Chi for cardiovascular wellness: Integrating an ancient practice into modern therapeutic approaches.

BioMedicine·2026
Same author

Therapeutic Modulation of Mitophagy by Cafestol in Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.

Nutrients·2025
Same author

Therapeutic Impact of Vericiguat on Ventricular Remodeling in a Pressure-Overload Heart Failure Model.

Life (Basel, Switzerland)·2025
Same author

Impact of venous thromboembolism on mortality in hospitalized patients with inflammatory bowel disease: analysis of the MIMIC-IV database, 2008 to 2022.

BMC gastroenterology·2025

Related Experiment Video

Updated: Jun 6, 2025

Protocol for the Evaluation of MRI Artifacts Caused by Metal Implants to Assess the Suitability of Implants and the Vulnerability of Pulse Sequences
08:19

Protocol for the Evaluation of MRI Artifacts Caused by Metal Implants to Assess the Suitability of Implants and the Vulnerability of Pulse Sequences

Published on: May 17, 2018

9.8K

Cardiotoxicity concerns in total joint arthroplasty.

Chun-Han Cheng1, Wen-Rui Hao2,3, Tzu-Hurng Cheng4

  • 1Department of Medical Education, Linkou Chang Gung Memorial Hospital, Taoyuan City 33305, Taiwan.

World Journal of Orthopedics
|November 27, 2024
PubMed
Summary

Elevated cobalt and titanium levels after total joint arthroplasty may harm cardiac function. Monitoring metal ion levels is crucial for reducing cardiovascular risk in these patients.

Keywords:
Cardiac functionCardiotoxicityCobaltJoint arthroplastyMetal ions

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.3K
Potentiodynamic Corrosion Testing
08:43

Potentiodynamic Corrosion Testing

Published on: September 4, 2016

17.5K

Related Experiment Videos

Last Updated: Jun 6, 2025

Protocol for the Evaluation of MRI Artifacts Caused by Metal Implants to Assess the Suitability of Implants and the Vulnerability of Pulse Sequences
08:19

Protocol for the Evaluation of MRI Artifacts Caused by Metal Implants to Assess the Suitability of Implants and the Vulnerability of Pulse Sequences

Published on: May 17, 2018

9.8K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.3K
Potentiodynamic Corrosion Testing
08:43

Potentiodynamic Corrosion Testing

Published on: September 4, 2016

17.5K

Area of Science:

  • Orthopedics
  • Cardiology
  • Biomaterials Science

Background:

  • Total joint arthroplasty (TJA) involves implanting artificial joints, often made of metal alloys.
  • Concerns exist regarding the potential release and systemic effects of metal ions from these implants.
  • Cardiotoxicity from elevated metal ion levels is an emerging area of clinical concern.

Discussion:

  • Brennan et al. investigated the link between elevated metal ion concentrations and cardiac effects post-TJA.
  • The study highlights that increased cobalt and titanium levels may negatively impact cardiac structure and function.
  • This raises important considerations for patient monitoring and management following arthroplasty.

Key Insights:

  • Elevated serum cobalt and titanium levels are associated with adverse cardiac outcomes in TJA patients.
  • Specific cardiac parameters may be affected, necessitating further investigation.
  • Clinical vigilance for cardiovascular complications in TJA recipients with high metal ion levels is warranted.

Outlook:

  • Further research is needed to elucidate the precise mechanisms of metal ion-induced cardiotoxicity.
  • Development of improved diagnostic and monitoring strategies for metal ion exposure is recommended.
  • Long-term cardiovascular surveillance protocols for TJA patients may need revision.